AMAT
55
-2
EXPE
66
-3
HBAN
70
3
SCHW
71
-2
EMN
73
25
GILD
65
2
FIS
58
-7
CVX
32
4
A
51
4
DNB
38
-14
AEP
56
2
PEP
33
4
BIIB
50
5
GT
46
-4
EIX
40
-11
ETN
69
-2
VTR
41
-2
KHC
25
5
NTRS
67
3
GD
50
2
AMAT
55
-2
EXPE
66
-3
HBAN
70
3
SCHW
71
-2
EMN
73
25
GILD
65
2
FIS
58
-7
CVX
32
4
A
51
4
DNB
38
-14
AEP
56
2
PEP
33
4
BIIB
50
5
GT
46
-4
EIX
40
-11
ETN
69
-2
VTR
41
-2
KHC
25
5
NTRS
67
3
GD
50
2
Financhill
Back

Castle Biosciences 10K Form

Sell
26

CSTL
Castle Biosciences

Last Price:
$15.96
Seasonality Move:
14.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-11-09 10Q CSTL/Castle Biosciences Quarterly
2020-08-10 10Q CSTL/Castle Biosciences Quarterly
2020-05-11 10Q CSTL/Castle Biosciences Quarterly
2020-03-10 10K CSTL/Castle Biosciences Annual
2019-11-12 10Q CSTL/Castle Biosciences Quarterly
2019-09-03 10Q CSTL/Castle Biosciences Quarterly

Receive CSTL News And Ratings

See the #1 stock for the next 7 days that we like better than CSTL

CSTL Financial Statistics

Sales & Book Value

Annual Sales: $332.1M
Cash Flow: $-10.8M
Price / Cash Flow: 11.2
Annual Sales: $15.26
Price / Book: 1.05

Profitability

EPS (TTM): -0.19000
Net Income (TTM): $-5.1M
Gross Margin: $271.9M
Return on Equity: -1.17%
Return on Assets: -1.02%

Castle Biosciences Earnings Forecast

Key Castle Biosciences Financial Ratios

  • The Gross Profit Margin over the past 8 years for CSTL is 81.87%.
  • The Selling, General & Administrative Expenses for CSTL have been equal to 60.24% of Gross Profit Margin.
  • The Research & Development expenses have been 15.67% of Revenue.
  • The Interest Expense is 3.16% of Operating Income.
  • The Net Earning history of CSTL is 5.49% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Castle Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: CSTL
CUSIP: 14843C
Website: castlebiosciences.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 9.37
Quick Ratio: 8.89

Price-to-Earnings

Trailing P/E Ratio: 25.73
Forward P/E Ratio: 0

CSTL Technical Analysis vs Fundamental Analysis

Sell
26
Castle Biosciences (CSTL) is a Sell

Is Castle Biosciences a Buy or a Sell?